Jiangxi Jinfeng Pharmaceutical

Jiangxi Jinfeng Pharmaceutical is a Chinese high-tech enterprise specializing in the research, development, production, and sale of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). Established in 2014 and headquartered in Shangrao, Jiangxi Province, the company operates a 52,000-square-meter manufacturing facility that is EU-GMP certified. Its product portfolio includes key intermediates and APIs for significant drugs such as Pregabalin, Enzalutamide, and Lurasidone, targeting therapeutic areas like oncology, neurology, and cardiovascular diseases. In addition to its proprietary product line, Jinfeng provides comprehensive CMO and CDMO services to global pharmaceutical companies, leveraging its R&D center in Shanghai and collaborations with academic institutions. The company maintains a strong focus on quality and environmental standards, holding ISO9001, ISO14001, and ISO45001 certifications.